A Multicentric and European Clinical Trial
RESSTORE is a translational project that will provide through a European multicentre randomised clinical study, essential information on safety and efficacy of intravenous cell therapy i.e. delivery of allogenic adipose tissue derived stem cells (ADSCs) in stroke patients.
The objective is to improve brain repair and recovery after ischemic stroke.
RESSTORE is funded by the European Commission H2020 programme.
Check out the project news
29 Partners from 5 Countries
Project dates: 2015-2020
Coordination: Grenoble Alpes University, France
Budget: 6.3 M€
RESSTORE Consortium gathers 29 partners from 5 countries (France, Spain, Finland, Czech Republic and UK)
including clinical centers, cell therapy units and experimental laboratories.
To see the full list of partners, visit the following webpage
RESSTORE Consortium at the 2nd Annual Meeting in Seville on 6th & 7th November 2017
RESSTORE project has received funding from the European Union’s Horizon 2020
research and innovation programme under grant agreement No 681044